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 Usher Syndrome type 1 (USH1) is the most severe form
of Usher syndrome [1] and is characterized by congenital pro-
found deafness, vestibular areflexia, and (generally) early on-
set of retinitis pigmentosa (RP). Six loci have been mapped
and five genes have been identified: myosin VIIa (MYO7A),
cadherin-23 (CDH23), protocadherin-15 (PCDH15), harmonin
(USH1C), and SANS (USH1G) [2,3]. MYO7A appears to be
the most frequently involved, and mutations have been re-
ported in 29-54 [4,5] percent of cases but there have been few
systematic studies on a cohort of patients [6,7].
The USH1F locus was mapped about ten years ago to
chromosome 10q21-22, and the PCDH15 gene was cloned in
2001 [8]. Several USH1F transcripts have been identified in
humans, and the longest isoform (isoform A), consisting of 1
noncoding and 32 protein-coding exons, encodes a 1955 amino
acid transmembrane protein that is predicted to contain 11
cadherin repeats, one transmembrane domain, and a cytoplas-
mic domain containing two proline-rich regions [8-10]. Re-
cently, multiple alternative protocadherin-15 transcripts were
characterized in the mouse inner ear. These transcripts define
four major isoform classes alternatively spliced, and two of
them encode new cytoplasmic domains, raising the number of
exons to 39. Three of these isoforms have different spatiotem-
poral expression patterns in developing and mature hair cells,
suggesting a specific role for each protocadherin-15 isoform
in the sensory hair bundle [11]. These alternatively spliced
exons encoding the two novel cytoplasmic domains were also
detected in human retina, indicating that the organization of
the human gene could be more complex than was initially
thought [11]. Together with other USH1 proteins
protocadherin-15 ensures hair bundle morphogenesis [12] via
its binding to harmonin [13,14] and myosin VIIa [15].
Around 25 mutations have been documented, nearly all
predicted to lead to premature termination of the proteins (6-
10). Ouyang et al. [6] studied PCDH15 together with other
USH1 genes in a cohort of patients and found PCDH15 muta-
tions in five patients but identified both causative mutations
in only one of them.
We present in this study an exhaustive analysis of the de-
letions that were detected in three different families [7]. We
show that not only are all deletions different, they also ac-
count for a significant proportion of PCDH15 mutations, prob-
ably because of the genomic structure of this gene. We sug-
gest that deletion screening should be part of the molecular
analysis for PCDH15 and any other genes that have such an
unusual genomic structure.
METHODS
Patients:  The project was approved by the local ethics com-
mittee. Consent to genetic testing was obtained from adult
probands or parents of minors. Patients meeting the diagnos-
tic criteria for USH1 were previously described [7]. USH1
was diagnosed on the basis of congenital profound sensorineu-
ral deafness, vestibular dysfunction, and retinal degeneration.
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102U153 and U297 were sporadic cases whereas two affected
siblings were available for family U382. All patients under-
went audiological examination and all presented with profound
deafness. The age of walking was delayed and ranged from
18 months (U153) to 36 months (U297). Electroretinograms
(ERG) and fundus examinations were altered in all cases when
diagnoses were made at 9 years old (U153 and U297). The
ERG was already extinguished at 4 years old in both siblings
in family U382.
Sequencing analysis of PCDH15: PCR amplification and
sequencing of the PCDH15 gene, corresponding to isoform A
as described by Ahmed et al. [10] (NM_033056), has already
been reported [7]. PCR parameters and primers have already
been published in the study from Roux et al. [7].
Haplotypes:  Haplotypes were constructed from a com-
bination of intragenic single nucleotide polymorphisms (SNPs)
and seven microsatellite markers: D10S1124-D10S2522-
PCDH15(IVS3-(CA)-D10S2536-D10S546)-D10S1643-
D10S1762. The location of the markers is reported in Figure
1A. Sequences of the microsatellite primers are available on
gdb with the exception of IVS3-(CA)-IVS3-F: 5'-GTA TGT
ACA GTT AAT TGG TAG-3'; IVS3-R: 5'-GAT GCA GGT
ATG GTT TCA G-3'.
Microsatellites were analyzed on an ABI 3100 Avant ge-
netic analyzer (Applied Biosystems, Applera France, France)
whereas the SNPs were analyzed by direct sequencing.
Semiquantitative assays:  Two semiquantitative ap-
proaches were used in parallel: the quantitative multiplex PCR
of short fluorescent fragments (QMPSF) and semiquantitative
nonfluorescent multiplex PCR. QMPSF containing multiplex
PCR of 3-9 amplicons were analyzed on an ABI310 (Applied
Biosystems). We applied to the PCDH15 gene the stategy used
by Audrezet et al. for the CFTR gene [16]. Semiquantitative
nonfluorescent multiplex PCR products were separated under
nondenaturing conditions on a liquid chromatography system
(3500 Wave HS system coupled to an HSD system,
Transgenomic, Elancourt, France) then quantified by fluores-
cent detection using a post column intercalation dye, based on
guidelines described by Dehainault et al. [17]. One advantage
of the semiquantitative nonfluorescent multiplex PCR ana-
lyzed on the 3500 Wave HS system is that the primers used
for routine sequencing can also be used to determine if a par-
ticular exon has been deleted.
To narrow down the deletion breakpoints, we used PCR
walking methods that included laboratory-designed amplicons
localized in a first step every 50 kb both upstream and down-
stream of the identified deletions. The primers were chosen
according to the sequence of the bacterial artificial chromo-
some (BAC) clones (their accession number is given in Fig-
ure 1A). Once a breakpoint was localized between two adja-
cent amplicons, further primers were designed for new
amplicons until this initial 50 kb distance was reduced to a
maximum 4 kb interval. Each breakpoint interval thus charac-
terized by PCR walking is positioned on the BAC clones (Fig-
ure 2A).
Identification of the junction fragment in patient U297:
Once proximal and distal amplicons were identified within 4
kb intervals, a junction fragment of 1.3 kb was obtained using
the forward primer of the proximal amplicon with the reverse
primer of the distal amplicon. Further internal primers (U297-
bkp-prox-F: 5'-TGA AGA AAC CAC TAA GAC TGA G-3'
and U297-bkp-dist-R: 5'-GTA GCC ATT GCA GGC ACA G-
3') enabled the sequencing of a 360 bp junction fragment.
Analysis of control DNA:  Guthrie cards were obtained
from the neonatal screening center GREPAM in Montpellier.
All samples were anonymously  referenced and neither phe-
notypic nor ethnic origin data were available. DNA was ex-
tracted using standard procedures. A total of 172 control DNAs
were amplified for the noncoding exon 1 and exon 2. We tested
88 DNAs using primers U297-bkp-prox-F and U297-bkp-dist-
R.
RESULTS
Haplotype analyses and evidence of the deletions:  We have
previously reported the screening for mutations in MYO7A,
CDH23, PCDH15, USH1C, and SANS in a cohort of 31 USH1
families [7]. While conducting a preliminary linkage analysis
using microsatellites surrounding each USH1 gene, we de-
tected apparent noninheritance of some markers or failure of
amplification among the USH1F panel (D10S1124;
D10S2522; IVS3-(CA); D10S2536; D10S546; D10S1643 and
D10S1762) in two families (U153, and U382) as shown on
Figure 1B. These results were confirmed by amplification in
neighboring regions. Microsatellite analysis was not informa-
tive in patient U297 but a deletion was suggested after an ap-
parently homozygous p.Arg290X mutation, localized in exon
8, was identified. This novel mutation appeared to be carried
on different haplotypes as revealed by heterozygous intronic
SNPs in the 3' end of the gene (Figure 1B).
The resulting haplotypes of the three pedigrees are pre-
sented in Figure 1B together with SNPs analyses when infor-
mative. Sequencing of the entire coding region of PCDH15
revealed that the patients were compound heterozygotes for
premature truncating mutations p.Ser144LeufsX15
(c.423_430dup) and p.Arg290X (c.868A>T) in trans to the
two deletions identified in U153 and U297. A third homozy-
gous deletion was identified in family U382 with a known
history of consanguinity.
Narrowing of the breakpoints:  To narrow down the dele-
tion breakpoints of the two compound heterozygous patients,
we used two semiquantitative PCR walking methods. The
narrowing of the deletion breakpoint in patient U382 was per-
formed by simple PCR walking, looking at the amplification
or nonamplification of each amplicon.
When each breakpoint was localized within an interval
below 4 kb, PCR was performed to identify the precise dele-
tion breakpoints. One breakpoint was identified (U297; see
Figure 2B). Unfortunately, several other attempts using dif-
ferent long-range PCR kits failed to identify a junction frag-
ment in the other two patients, suggesting that the deletions
may be more complex than anticipated.
PCR walking in patient U382 narrowed the deletion to a
proximal breakpoint localized within a 1.6 kb interval in the
5' region of the PCDH15 gene and to a distal breakpoint lying
©2007 Molecular Vision Molecular Vision 2007; 13:102-7 <http://www.molvis.org/molvis/v13/a12/>
103in IVS1 within an 1.4 kb interval. The size of the deletion is
estimated as 190 kb (Figure 1 and Figure 2). None of the 172
control DNAs showed an absence of amplification of exon 1
excluding a similar homozygous deletion in these controls.
The deletion in patient U153 was originally character-
ized as spanning exons 3-5 by means of the intragenic marker
D10S2536 and SNP. However this deletion was further char-
acterized as extending from a proximal breakpoint within IVS1,
within an interval of 3.5 kb, to a distal breakpoint within an
0.8 kb interval of IVS5 (Figure 1 and Figure 2). The size of
the deletion is about 341 kb. None of the 172 control DNAs
showed an absence of amplification of exon 2, excluding an
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Figure 1. Pedigrees at the USH1F locus.  A: Genomic organization of the PCDH15 isoform A with numbering of the exons as described by
Ahmed et al. [10] NM_033056. The noncoding exon 1 is represented in grey. Positions of the BAC clones and the microsatellite markers are
indicated. B: Representation of the three pedigrees with haplotypes. (-) represents lack of amplification; N represents normal. In the first
pedigree “Ins” stands for the c.423_430dup mutation (insertion of 7 bp). The different haplotypes are indicated by rectangles with various
fillings.
104homozygous deletion spanning at least this exon in these con-
trols.
The deletion in patient U297 was narrowed down by
semiquantitative PCR then further characterized by amplifi-
cation of a junction fragment (Figure 2B). The deletion spans
about 684 kb, includes exon 8, and is in trans to the p.Arg290X
mutation (Figure 1 and Figure 2). The proximal breakpoint,
lies within 2.4 kb of U382 breakpoint, but is not identical.
This junction fragment was not detected in 176 alleles (i.e.,
88 control DNAs).
DISCUSSION
 None of the deletions described in this paper have been found
in normal controls, and they would all result in nonfunctional
protein. Recent data has shown that multiple isoforms exist.
No exon is present in all identified so far alternative transcripts
[11]. However, no isoform has been observed to containing
deletions extending from exon 2 to exon 5 or 8. In addition, an
Arg3X mutation in the second exon has been observed in two
patients, providing evidence that the presence of the first few
exons is necessary [8,9]. Recently, an alternatively spliced
isoform (lacking exons 3-15) was found to circumvent the ef-
fect of the mutant allele IVS14-2A>G in the homozygous
Pcdh15av-5J mice [18]. Such a mechanism is not likely to be
involved here as the patients described in this study are af-
fected with typical USH1.
The six intervals surrounding the breakpoints were placed
on the BAC clones (NCBI Accession numbers given in Fig-
ure 1A and Figure 2A) and analyzed through repeat masker
(repeatmasker). Although short interspersed elements (SINE),
long interspersed elements (LINE), and long terminal repeats
(LTR) were found in all cases (Figure 2A), there is no evi-
dence for direct repeats or duplicons as found in some other
cases of recurrent deletion or duplication. In patient U297 the
only obvious feature at the breakpoint is a repetition of GAA
(Figure 2B). This is in line with the findings in studies of de-
letions of the dystrophin gene in DMD [19] and duplications
of PLP1 in Pelizaeus-Merzbacher disease [20].
A detailed analysis of the gene structure provides a likely
explanation for the high rate of such deletions. The gene spans
nearly 1 Mb for a corresponding ORF of 7,021 bp. The intron
size of PCDH15 is up to 150 kb, and the first three exons of
the gene cover 0.42 Mb. The six breakpoint intervals lie in
introns ranging from 22 to 140 kb in size localized in the first
third of the gene.
Because of the large size of PCDH15 and, in particular,
the low proportion which is coding, predominantly in the 5'
end of the gene, it is not surprising that large deletions, with
differing breakpoints, form a significant proportion of
PCDH15 mutations (30% in our cohort) which represents
nearly 10% of all USH1 patients [7]. The situation is reminis-
cent of the high frequency of deletions within the dystrophin
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Figure 2. Schematic localization of the deletion breakpoints on the PCDH15 gene and their analysis.  A: Localization of the six deletion
breakpoints on the bacterial artificial chromosome (BAC) clones. B: The breakpoint junction fragment identified in patient U297 is aligned
with the wild-type sequences spanning the 5' and 3' breakpoints. The deleted sequences are crossed out.
105gene found in patients with Duchenne Muscular Dystrophy.
The dystrophin gene coding region of 11 kb is encoded over
2.4 Mb of genomic DNA. Around 60% of mutations are large
deletions [21], and many occur within the two large introns 7
and 44 [22].
This observation has several implications. First, although
an initial linkage analysis approach was incorporated to target
which gene was the best candidate for mutation screening, it
may also identify apparent noninheritance of markers. Sec-
ond, these results show that restricting the molecular analysis
of PCDH15 in USH1F to sequencing is not sufficient, and
testing for large genomic rearrangements is recommended. A
previous study has described only one PCDH15 mutation in
patients [6]. It is possible that either a large genomic deletion
or a mutation lying in the additional exons [11] accounts for
the second pathogenic mutation in these patients. Detection
of large genomic rearrangements is becoming easier and more
routine with the development of methods such as multiplex
ligation-dependent probe amplification (MLPA) and multiplex
amplifiable probe hybridization (MAPH) [23] and should be
considered, particularly for genes with an extended genomic
structure. Third, large genomic rearrangement analysis can-
not be routinely achieved by PCR of junction fragments as
each deletion appears to be different and is likely to be inef-
fective across breakpoints involving complex rearrangements.
PCR may still be customized by semiquantitative PCR, or other
methods, such as MLPA, may be developed.
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